Cannabidiol

Patients for whom conventional treatments provide insufficient results may seek alternative treatments, such as cannabidiol (CBD), to mitigate symptoms, enhance quality of life and well-being, boost the immune system, or treat a disease (Richardson et al., 2000; Sparber et al., 2000). CASE STUDY A 6...

Full description

Saved in:
Bibliographic Details
Published inClinical journal of oncology nursing Vol. 25; no. 4; pp. 405 - 412
Main Authors Butler, Taylor W, Hande, Karen, Ryan, Michelle, Raman, Rameela, McDowell, Rachel, Cones, Bethany, Jackson PhD APRN FNP-BC NEA-BC, Heather Jane, Cortez, Manuel, Murphy, Barbara A
Format Journal Article
LanguageEnglish
Published Pittsburgh Oncology Nursing Society 01.08.2021
Subjects
Anxiety
Back pain
Cancer therapies
Cannabidiol
Case reports
Chemotherapy
Clinical trials
Drug use
Fatigue
FDA approval
Marijuana
Medical diagnosis
Multiple myeloma
Narcotics
Nausea
Oncology
Pain
Pain management
Patients
Peripheral neuropathy
Quality of life
Side effects
United States > US
Online AccessGet full text

Cover

More Information
Summary:Patients for whom conventional treatments provide insufficient results may seek alternative treatments, such as cannabidiol (CBD), to mitigate symptoms, enhance quality of life and well-being, boost the immune system, or treat a disease (Richardson et al., 2000; Sparber et al., 2000). CASE STUDY A 62-year-old man with a history of multiple myeloma presents with fatigue, chemotherapy-induced peripheral neuropathy, and back pain. According to the National Cancer Institute (2018), the only documented benefits of CBD include anxiolytic, antiemetic, and anti-inflammatory effects. Two additional studies examined participants' pain relief during kidney transplantation and acute graft-versus-host disease after a bone marrow transplantation; again, the results were inconclusive because of sample size (Cuñetti et al., 2018; Yeshurun et al., 2015).
ISSN:1092-1095
1538-067X
DOI:10.1188/21.CJON.405-412